Tag: Cancer: Colon
FDA Approves Lonsurf for Metastatic Colorectal Cancer
For patients with metastatic CRC previously treated with chemotherapy, biological therapy
Regorafenib Deemed Not Cost-Effective for Metastatic CRC
Findings based on its use as third-line treatment of metastatic colorectal cancer
EHR Triggers Cut Time to Diagnostic Cancer Evaluation
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer
Oncology Care Often Received at Multiple Hospitals
More than a third of colon cancer patients in study get care from different facilities
USPSTF Recommendations for Aspirin Use Vary by Age
Recommended for some patients aged 50 to 59 years; insufficient evidence for those <50, ≥70
Dual-Modality DRS-FS Discerns Tumor From Surrounding Tissue
Diffuse reflectance spectroscopy-fluorescence spectroscopy sensitive, specific in colorectal cancer
Social Distress ID’d in Minority of Colorectal Cancer Survivors
Strongest predictor of social distress is having three or more long-term conditions
Low-Dose Aspirin, Other NSAIDs May Lower Colorectal Cancer Risk
Findings for consistent use over 5 or more years
Drinking Coffee May Cut Risk of Death in Stage III Colon Cancer
Patients consuming ≥4 cups/day of caffeinated coffee have lower recurrence, mortality risk
Index Stratifies Risk for Advanced Colorectal Neoplasia
Authors suggest scoring system may allow tailoring of screening methods in those at average risk
